[Rhabdomyolysis in neuroleptic therapy: an abortive malignant neuroleptic syndrome?].
We report on the case of a 24 year old female patient, who, at first developed during 8 weeks of neuroleptic therapy parkinsonism and then, after improvement of psychopathology an acute rhabdomyolysis. Hyper-Ck-aemia up to 11,340 U/l was observed. Laboratory parameters normalized shortly after neuroleptics had been withdrawn and no further complications followed. Symptomatology is discussed with special reference to the possibility of an abortive malignant neuroleptic syndrome.
Peschel
O
O
Psychiatrische Klinik, Universität München.
Kurtz
G
G
Müller-Felber
W
W
Modell
S
S
D000328:Adult; D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D003402:Creatine Kinase / Q000097:blood; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008111:Liver Function Tests; D009459:Neuroleptic Malignant Syndrome / Q000175:diagnosis* / Q000201:enzymology; D009460:Neurologic Examination / Q000187:drug effects; D010302:Parkinson Disease, Secondary / Q000139:chemically induced / Q000175:diagnosis / Q000201:enzymology; D011618:Psychotic Disorders / Q000175:diagnosis / Q000188:drug therapy* / Q000523:psychology; D012206:Rhabdomyolysis / Q000139:chemically induced* / Q000201:enzymology
D014150:Antipsychotic Agents; D003402:Creatine Kinase
Rhabdomyolyse unter Neuroleptikatherapie: ein abortives malignes neuroleptisches Syndrom?